Abstract
One of the most frequent causes of maternal and perinatal morbidity is represented by hypertensive disorders during pregnancy. Women at high risk must be subjected to a more intensive antenatal surveillance and prophylactic treatments. Many genetic risk factors, clinical features and biomarkers have been proposed but none of these seems able to prevent pre-eclampsia onset. English literature review of manuscripts focused on calcium intake and hypertensive disorders during pregnancy was performed. We performed a critical analysis of evidences about maternal calcium metabolism pattern in pregnancy analyzing all possible bias affecting studies. Calcium supplementation seems to give beneficial effects on women with low calcium intake. Some evidence reported that calcium supplementation may drastically reduce the percentage of pre-eclampsia onset consequently improving the neonatal outcome. Starting from this evidence, it is intuitive that investigations on maternal calcium metabolism pattern in first trimester of pregnancy could represent a low cost, large scale tool to screen pregnant women and to identify those at increased risk of pre-eclampsia onset. We propose a biochemical screening of maternal calcium metabolism pattern in first trimester of pregnancy to discriminate patients who potentially may benefit from calcium supplementation. In a second step we propose to randomly allocate the sub-cohort of patients with calcium metabolism disorders in a treatment group (calcium supplementation) or in a control group (placebo) to define if calcium supplementation may represent a dietary mean to reduce pre-eclampsia onset and to improve pregnancy outcome.
References
1. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2014;6:CD001059.10.1002/14651858.CD001059.pub4Search in Google Scholar PubMed
2. Savaj S, Vaziri N. An overview of recent advances in pathogenesis and diagnosis of preeclampsia. Iran J Kidney Dis 2012;6:334–8.Search in Google Scholar
3. Villar J, Abalos E, Nardin JM, Merialdi M, Carroli G. Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials. Semin Nephrol 2004;24:607–15.10.1016/j.semnephrol.2004.07.009Search in Google Scholar
4. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159–219.10.1093/eurheartj/eht151Search in Google Scholar PubMed
5. Carroli G, Duley L, Belizán JM, Villar J. Calcium supplementation during pregnancy: a systematic review of randomised controlled trials. Br J Obstet Gynaecol 1994;101:753–8.10.1111/j.1471-0528.1994.tb11940.xSearch in Google Scholar PubMed
6. Repke JT, Villar J. Pregnancy-induced hypertension and low birth weight: the role of calcium. Am J Clin Nutr 1991;54:237S–241S.Search in Google Scholar
7. Powers RW, Catov JM, Bodnar LM, Gallaher MJ, Lain KY, Roberts JM. Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome. Reprod Sci 2008;15:374–81.10.1177/1933719107311780Search in Google Scholar PubMed PubMed Central
8. Lockwood CJ, Yen CF, Basar M, Kayisli UA, Martel M, Buhimschi I, et al. Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am J Pathol 2008;172:1571–9.10.2353/ajpath.2008.070629Search in Google Scholar PubMed PubMed Central
9. Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 2005;193:429–36.10.1016/j.ajog.2004.12.014Search in Google Scholar PubMed
10. Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. Can Med Assoc J 2008;178:701–11.10.1503/cmaj.070430Search in Google Scholar PubMed PubMed Central
11. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116:402–14.10.1097/AOG.0b013e3181e9322aSearch in Google Scholar PubMed
12. Velauthar L, Plana MN, Kalidindi M, Zamora J, Thilaganathan B, Illanes SE, et al. Uterine artery Doppler in the first trimester as a risk factor for adverse pregnancy outcomes: a meta-analysis involving 55,974 women. Ultrasound Obstet Gynecol 2014;43:500–7.10.1002/uog.13275Search in Google Scholar PubMed
13. Goetzinger KR, Zhong Y, Cahill AG, Odibo L, Macones GA, Odibo AO. Efficiency of first-trimester uterine artery Doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein a, and maternal characteristics in the prediction of preeclampsia. J Ultrasound Med 2013;32:1593–600.10.7863/ultra.32.9.1593Search in Google Scholar PubMed PubMed Central
14. Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2008;12:iii–iv,1–270.10.3310/hta12060Search in Google Scholar PubMed
15. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev 2006;3:CD003402.10.1002/14651858.CD003402.pub2Search in Google Scholar PubMed
16. Basaran A, Basaran M, Topatan B. Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis. Obstet Gynecol Surv 2010;65:653–67.10.1097/OGX.0b013e3182095366Search in Google Scholar PubMed
17. Patrelli TS, Dall’asta A, Gizzo S, Pedrazzi G, Piantelli G, Jasonni VM, et al. Calcium supplementation and prevention of preeclampsia: a meta-analysis. J Matern Fetal Neonatal Med 2012;25:2570–4.10.3109/14767058.2012.715220Search in Google Scholar PubMed
18. Imdad A, Bhutta ZA. Effects of calcium supplementation during pregnancy on maternal, fetal and birth outcomes. Paediatr Perinat Epidemiol 2012;26:138–52.10.1111/j.1365-3016.2012.01274.xSearch in Google Scholar PubMed
19. Richards DG, Lindow SW, Carrara H, Knight R, Haswell SJ, Van der Spuy ZM. A comparison of maternal calcium and magnesium levels in pre-eclamptic and normotensive pregnancies: an observational case-control study. Br J Obstet Gynaecol 2014;121:327–36.10.1111/1471-0528.12436Search in Google Scholar PubMed
20. Kim J, Kim YJ, Lee R, Moon JH, Jo I. Serum levels of zinc, calcium, and iron are associated with the risk of preeclampsia in pregnant women. Nutr Res 2012;32:764–9.10.1016/j.nutres.2012.09.007Search in Google Scholar PubMed
21. Hofmeyr G, Belizán J, von Dadelszen P, Calcium and Pre-eclampsia (CAP) Study Group. Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary.. Br J Obstet Gynaecol 2014;121:951–7.10.1111/1471-0528.12613Search in Google Scholar PubMed PubMed Central
22. Carroli G, Merialdi M, Wojdyla D, Abalos E, Campodonico L, Yao SE, et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low-calcium-intake mothers: a randomized controlled trial. Am J Obstet Gynecol 2010;202:45.e1–9.10.1016/j.ajog.2009.07.037Search in Google Scholar PubMed
23. Jain S, Sharma P, Kulshreshtha S, Mohan G, Singh S. The role of calcium, magnesium, and zinc in pre-eclampsia. Biol Trace Elem Res 2010;133:162–70.10.1007/s12011-009-8423-9Search in Google Scholar PubMed
24. Yang H, Kim TH, An BS, Choi KC, Lee HH, Kim JM, et al. Differential expression of calcium transport channels in placenta primary cells and tissues derived from preeclamptic placenta. Mol Cell Endocrinol 2013;367:21–30.10.1016/j.mce.2012.12.012Search in Google Scholar PubMed
25. Tomaschitz A, Pilz S. Interplay between sodium and calcium regulatory hormones: a clinically relevant research field. Hypertension 2014;63:212–4.10.1161/HYPERTENSIONAHA.113.02253Search in Google Scholar PubMed
26. Kumar A, Devi SG, Prasad S, Kapoor S, Sharma S. Bone turnover in preeclampsia-complicated pregnancy in North Indian women. J Obstet Gynaecol Res 2012;38:172–9.10.1111/j.1447-0756.2011.01664.xSearch in Google Scholar PubMed
27. Shaarawy M, Zaki S, Ramzi AM, Salem ME, El-Minawi AM. Feto-maternal bone remodeling in normal pregnancy and pre-eclampsia. J Soc Gynecol Investig 2005;12:343–8.10.1016/j.jsgi.2005.02.014Search in Google Scholar PubMed
28. Anim-Nyame N, Sooranna SR, Jones J, Alaghband-Zadeh J, Steer PJ, Johnson MR. A longitudinal study of biochemical markers of bone turnover during normal pregnancy and pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 2002;109:708–13.10.1111/j.1471-0528.2002.00353.xSearch in Google Scholar PubMed
29. Mozzanega B, Gizzo S, Bernardi D, Salmaso L, Patrelli TS, Mioni R, et al. Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle. J Bone Miner Metab 2013;31:461–7.10.1007/s00774-013-0430-4Search in Google Scholar PubMed
30. Gizzo S, Noventa M, Saccardi C, Paccagnella G, Patrelli TS, Cosmi E, et al. Twin pregnancy after kidney transplantation: what’s on? A case report and review of literature. J Matern Fetal Neonatal Med 2014. [Epub ahead of print 2014 Feb 3]. PubMed PMID: 24397798.10.3109/14767058.2013.879699Search in Google Scholar PubMed
31. Shen P, Gong Y, Wang T, Chen Y, Jia J, Ni S, et al. Expression of osteoprotegerin in placenta and its association with preeclampsia. PLoS One 2012;7:e44340.10.1371/journal.pone.0044340Search in Google Scholar PubMed PubMed Central
32. Dorota DK, Bogdan KG, Mieczyslaw G, Bozena LG, Jan O. The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. Hypertens Pregnancy 2012;31: 166–76.10.3109/10641955.2010.484084Search in Google Scholar PubMed
©2015 by De Gruyter
